Results 181 to 190 of about 44,308 (198)
Some of the next articles are maybe not open access.

Properties of the mantle cell and mantle cell lymphoma

Current Opinion in Hematology, 2002
The major lymphoid inhabitant of the follicular mantle is the mantle cell, an immunologically naïve B cell. It is the putative cell of origin of mantle cell lymphoma (MCL), the cells of which have similar morphologic, immunophenotypic, and molecular characteristics to the normal B lymphocytes of the mantle zone.
John L. Frater, Eric D. Hsi
openaire   +3 more sources

Mantle Cell Lymphoma

Advances in Anatomic Pathology, 1998
Mantle cell lymphomas comprise 2 to 8% of non-Hodgkin's lymphoma in the United States. They occur in older adults with a distinct male predominance, who present with generalized lymphadenopathy, and often have disseminated disease at the time of diagnosis.
openaire   +3 more sources

Mantle Cell Lymphoma [PDF]

open access: possible, 2013
Mantle cell lymphoma (MCL) is a B-cell neoplasm thought to derive from mantle zone B-cells and characterized by translocations involving the CCND1 gene, most commonly t(11;14)(q13;q23). The classical variant of MCL is comprised of small- to medium-sized cells with irregular nuclear contours.
Roberto N. Miranda   +2 more
openaire   +1 more source

Mantle-Cell Lymphoma

New England Journal of Medicine, 2022
James O, Armitage, Dan L, Longo
openaire   +4 more sources

Mantle Cell Lymphoma: An Update

Leukemia & Lymphoma, 1992
Mantle cell lymphoma is a distinctive pathologic entity that incorporates the previous histopathologic categories of centrocytic lymphoma and lymphocytic lymphoma of intermediate differentiation. These lymphomas are characterized by common histologic and immunologic characteristics that suggest derivation from the follicular mantle zone.
Elaine S. Jaffe   +3 more
openaire   +3 more sources

Mantle cell lymphoma

Clinical Lymphoma Myeloma and Leukemia, 2017
Mr HK is a 67-year-old Caucasian man with a past medical history of hypertension. He presented to his primary care physician’s office in June 2014 with 3 months’ history of fever, fatigue, and an enlarged cervical lymph node.
openaire   +4 more sources

Lenalidomide for mantle cell lymphoma

Expert Review of Hematology, 2015
Mantle cell lymphoma accounts for 6% of all non-Hodgkin lymphomas. It is a biologically and clinically heterogeneous disease and treatment may be difficult, since most patients present at an older age, being unable to undergo intensive chemotherapy. Lenalidomide is an approved medication for relapsed mantle cell lymphoma in patients who received at ...
Alan P Skarbnik, Andre Goy
openaire   +3 more sources

Mantle Cell Lymphoma

2019
Mantle cell lymphoma (MCL) of the ocular adnexa does not differ from systemic mantle cell lymphoma in its biological and clinical behaviour. As the name suggests, it arises from the mantle zone of the lymphoid follicles. It is a mature B-cell lymphoma, which is much less common than the other subtypes of B-cell lymphomas, and has an aggressive clinical
Bingcheng Wu   +5 more
openaire   +4 more sources

Mantle-Cell Lymphomas of the Skin

Dermatologic Clinics, 1994
The skin lesions of two elderly women lead us to the diagnosis of small cleaved lymphocytic B-cell non-Hodgkin's lymphoma, TNM stage IVb after clinical staging examinations. Relapses occurred within less than 1 year. Morphology, enzymhistochemistry (alkaline phosphatase in the first case), and immunohistochemistry (CD 5 positivity in the second case ...
M.L. Geerts, Anne-Marie Busschots
openaire   +3 more sources

Mantle-cell lymphoma

Gastrointestinal Endoscopy, 2005
Wei Ming Sun   +2 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy